Active	Status	Sponsor type	Region	Phase	Filter
7 Active 2 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Pan, Jingwei
NCT03388593: Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.	Recruiting	3	1600	RoW	rhNRG-1, Neucardin™, Placebo	Zensun Sci. & Tech. Co., Ltd.	Chronic Heart Failure	02/26	02/26
Li, Yanhong
NCT05341115 / 2022-002471-11: A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty	Recruiting	4	80	RoW	Leuprorelin Acetate Depot 3M, Leuprolide acetate Depot 3M	Takeda, Takeda	Central Precocious Puberty	05/25	05/25
NCT03388593: Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.	Recruiting	3	1600	RoW	rhNRG-1, Neucardin™, Placebo	Zensun Sci. & Tech. Co., Ltd.	Chronic Heart Failure	02/26	02/26
NCT05493709: Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects with Central Precocious Puberty	Recruiting	3	93	US, RoW	Leuprolide Mesylate, Subcutaneous injection of 42 mg Leuprolide	Foresee Pharmaceuticals Co., Ltd., QPS Holdings LLC, Changchun GeneScience Pharmaceutical Co., Ltd.	Puberty; Precocious, Central	11/25	06/26